BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34849858)

  • 21. Allele-specific splicing effects on DKKL1 and ZNF419 transcripts in HeLa cells.
    Martin G; Selcuklu SD; Schouest K; Nembaware V; McKeown PC; Seoighe C; Spillane C
    Gene; 2017 Jan; 598():107-112. PubMed ID: 27826023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383.
    Reynard LN; Bui C; Syddall CM; Loughlin J
    Hum Genet; 2014 Aug; 133(8):1059-73. PubMed ID: 24861163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
    Zhang P; Tillmans LS; Thibodeau SN; Wang L
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator.
    Swift-Scanlan T; Smith CT; Bardowell SA; Boettiger CA
    BMC Med Genomics; 2014 Jan; 7():5. PubMed ID: 24460628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
    Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
    Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare genetic variation at transcription factor binding sites modulates local DNA methylation profiles.
    Martin-Trujillo A; Patel N; Richter F; Jadhav B; Garg P; Morton SU; McKean DM; DePalma SR; Goldmuntz E; Gruber D; Kim R; Newburger JW; Porter GA; Giardini A; Bernstein D; Tristani-Firouzi M; Seidman JG; Seidman CE; Chung WK; Gelb BD; Sharp AJ
    PLoS Genet; 2020 Nov; 16(11):e1009189. PubMed ID: 33216750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulated expression of the TPβ isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer.
    O'Sullivan AG; Eivers SB; Mulvaney EP; Kinsella BT
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3153-3169. PubMed ID: 28890397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer.
    Damaschke NA; Yang B; Blute ML; Lin CP; Huang W; Jarrard DF
    Neoplasia; 2014 Dec; 16(12):1018-27. PubMed ID: 25499215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm.
    Cho NY; Kim JH; Moon KC; Kang GH
    Virchows Arch; 2009 Jan; 454(1):17-23. PubMed ID: 19048291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set.
    Thibodeau SN; French AJ; McDonnell SK; Cheville J; Middha S; Tillmans L; Riska S; Baheti S; Larson MC; Fogarty Z; Zhang Y; Larson N; Nair A; O'Brien D; Wang L; Schaid DJ
    Nat Commun; 2015 Nov; 6():8653. PubMed ID: 26611117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
    Allen EK; Randolph AG; Bhangale T; Dogra P; Ohlson M; Oshansky CM; Zamora AE; Shannon JP; Finkelstein D; Dressen A; DeVincenzo J; Caniza M; Youngblood B; Rosenberger CM; Thomas PG
    Nat Med; 2017 Aug; 23(8):975-983. PubMed ID: 28714988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue.
    van den Oord EJ; Clark SL; Xie LY; Shabalin AA; Dozmorov MG; Kumar G; ; Vladimirov VI; Magnusson PK; Aberg KA
    Schizophr Bull; 2016 Jul; 42(4):1018-26. PubMed ID: 26656881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa.
    Takano H; Shibata T; Nakamura M; Sakurai N; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Otsuka T; Tahara T; Arisawa T
    BMC Med Genet; 2020 Oct; 21(1):205. PubMed ID: 33066747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allele-specific methylation contributed by CpG-SNP is associated with regulation of ALOX5AP gene expression in ischemic stroke.
    Shi Y; Xu L; Feng Q; Li A; Jia J; Xu Y; Yang D; Zhang Y; Zhang X; Zhao H; Wang J; He Y; Zheng H
    Neurol Sci; 2018 Oct; 39(10):1717-1724. PubMed ID: 30003372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.
    Chen H; Yu H; Wang J; Zhang Z; Gao Z; Chen Z; Lu Y; Liu W; Jiang D; Zheng SL; Wei GH; Issacs WB; Feng J; Xu J
    Prostate; 2015 Sep; 75(12):1264-76. PubMed ID: 26015065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets.
    Dayeh TA; Olsson AH; Volkov P; Almgren P; Rönn T; Ling C
    Diabetologia; 2013 May; 56(5):1036-46. PubMed ID: 23462794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
    Li X; Zhang W; Song J; Zhang X; Ran L; He Y
    Clin Epigenetics; 2019 Jul; 11(1):99. PubMed ID: 31288850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
    Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
    Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers.
    Sathyanarayanan A; Tanha HM; Mehta D; Nyholt DR
    Commun Biol; 2022 Jun; 5(1):594. PubMed ID: 35710732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer.
    Bhasin JM; Lee BH; Matkin L; Taylor MG; Hu B; Xu Y; Magi-Galluzzi C; Klein EA; Ting AH
    Cell Rep; 2015 Dec; 13(10):2135-46. PubMed ID: 26628371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.